Moberg Pharma AB

At a glance

Most recent filing on November 24, 2019 — an option exercise by Torbjörn Wärnheim on Nov 22, 2019.

We hold 7 visible filings, going back to November 22, 2019.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

5 of 7 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 7. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Torbjörn Wärnheim SVP R&D
308,528 SEKOption exercise
TradedNov 22, 2019FiledNov 24, 2019
Annika Christine Magnusson Senior Director Regulatory Affairs
187,395 SEKOption exercise
TradedNov 22, 2019FiledNov 23, 2019
Peter Wolpert Board member or deputy board member
20,246,054 SEKOption exercise
TradedNov 22, 2019FiledNov 22, 2019
Mark Beveridge Chief financial officer
793,476 SEKOption exercise
TradedNov 22, 2019FiledNov 22, 2019
Mattias Klintemar Board member or deputy board member
325,500 SEKOption exercise
TradedNov 22, 2019FiledNov 22, 2019